Bellwether Bio (Seattle, WA), 2017 to present: Liquid biopsy technology development

Matrix Genetics (Seattle, WA), 2013 to 2017: Genome engineering of cyanobacteria strains

Merck Research Labs(Palo Alto, CA), 2011 to 2013: Protein production to support drug discovery

Amgen Cell Sciences (Seattle, WA), 2010-2011: Characterization of mAb producing CHO cells

UCLA (Los Angeles, CA), 2003-2009: Metabolic engineering of hepatocyte lipid degredation